Literature DB >> 10719091

Reduction of ischemic brain injury by topical application of insulin-like growth factor-I after transient middle cerebral artery occlusion in rats.

J M Wang1, T Hayashi, W R Zhang, K Sakai, Y Shiro, K Abe.   

Abstract

In order to examine the effect of insulin-like growth factor-1 (IGF-1) on ischemic brain injury, IGF-1 was applied topically on the surface of reperfused rat brain after 60 min of transient middle cerebral artery occlusion (MCAO). In contrast to the cases treated with vehicle, the infarct area was greatly reduced at 24 h of reperfusion by treatment with IGF-1. Terminal deoxynucleotidyl transferase mediated dUTP-biotin in situ nick labeling (TUNEL) staining and immunoreactivity for glycogen synthase kinase 3beta (GSK3beta) were also markedly reduced in the brains with IGF-1 treatment. The present results suggest that the treatment with IGF-1 significantly ameliorates brain injury after transient focal brain ischemia associated with the reduction of TUNEL and GSK3beta stainings.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10719091     DOI: 10.1016/s0006-8993(00)02008-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  22 in total

1.  Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats.

Authors:  Robyn Balden; Amutha Selvamani; Farida Sohrabji
Journal:  Endocrinology       Date:  2012-03-09       Impact factor: 4.736

Review 2.  Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke.

Authors:  Farida Sohrabji; Amutha Selvamani; Robyn Balden
Journal:  Horm Behav       Date:  2012-06-19       Impact factor: 3.587

3.  Mild hypothermia decreases GSK3beta expression following global cerebral ischemia.

Authors:  Stephen Kelly; Danye Cheng; Gary K Steinberg; Midori A Yenari
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

4.  Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection.

Authors:  Chee Yeun Chung; Hyemyung Seo; Kai Christian Sonntag; Andrew Brooks; Ling Lin; Ole Isacson
Journal:  Hum Mol Genet       Date:  2005-05-11       Impact factor: 6.150

Review 5.  Intranasal Insulin and Insulin-Like Growth Factor 1 as Neuroprotectants in Acute Ischemic Stroke.

Authors:  Vasileios-Arsenios Lioutas; Freddy Alfaro-Martinez; Francisco Bedoya; Chen-Chih Chung; Daniela A Pimentel; Vera Novak
Journal:  Transl Stroke Res       Date:  2015-06-05       Impact factor: 6.829

6.  The neurotoxic effects of estrogen on ischemic stroke in older female rats is associated with age-dependent loss of insulin-like growth factor-1.

Authors:  Amutha Selvamani; Farida Sohrabji
Journal:  J Neurosci       Date:  2010-05-19       Impact factor: 6.167

7.  Genes and outcome after aneurysmal subarachnoid haemorrhage.

Authors:  Y M Ruigrok; A J C Slooter; A Bardoel; C J M Frijns; G J E Rinkel; C Wijmenga
Journal:  J Neurol       Date:  2005-02-23       Impact factor: 4.849

8.  Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1.

Authors:  Juan C Chavez; Joseph C LaManna
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

Review 9.  Cell death in the nervous system: lessons from insulin and insulin-like growth factors.

Authors:  Isabel Varela-Nieto; Enrique J de la Rosa; Ana I Valenciano; Yolanda León
Journal:  Mol Neurobiol       Date:  2003-08       Impact factor: 5.590

10.  Insulin-like Growth Factor (IGF)-1 treatment stabilizes the microvascular cytoskeleton under ischemic conditions.

Authors:  Shameena Bake; Andre Okoreeh; Homa Khosravian; Farida Sohrabji
Journal:  Exp Neurol       Date:  2018-10-01       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.